K-numberK242772
Device nameAirSurgN Insufflator (10030/AirSurgN)
ApplicantSmartsurgN, Inc.
Product codeHIF
Device classClass II
Decision dateApr 11, 2025
DecisionSubstantially Equivalent
Regulation884.1730
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The AirSurgN Insufflator is a microprocessor-based CO2 insufflator used during diagnostic and therapeutic laparoscopic procedures to distend the abdominal cavity and maintain pneumoperitoneum. It features an LCD touchscreen interface for user control of pressure (1-30 mmHg) and flow rate (1-50 L/min), includes automatic pressure relief, and provides vacuum-based smoke evacuation functionality.

Technological characteristics

The AirSurgN Insufflator matches its predicate device (PNEUMOCLEAR K170784) in distension medium (CO2), user interface type (LCD touchscreen), flow range (1-50 L/min), pressure range (1-30 mmHg), automatic pressure relief, electrical compliance (100-240 VAC), and safety/EMC standards. Key differences are that the subject device omits indications for pediatric use and additional cavity types (saphenous vein, colon, rectum), does not include tubing in the package, and has slightly smaller physical dimensions.

Test standards cited

IEC 60601-1:2005/AI:2012 and ANSI/AAMI ES60601-1:2005(R)2012 for electrical safety; IEC 60601-1-2 Edition 4.1 En:2020-09 for electromagnetic compatibility; IEC 62304:2006/A1:2016 for software life cycle processes; and the 2023 FDA Guidance on device software functions.

Substantial equivalence argument

Both devices are CO2 insufflators with identical core functionality for abdominal cavity insufflation during laparoscopic surgery. The subject device has reduced scope (abdominal cavity only, no pediatric modes) compared to the predicate, which does not create new safety or effectiveness questions but rather demonstrates a subset of functionality. Performance testing shows equivalent or superior results in pressure accuracy, flow delivery, volume accuracy, transient leaks, and overpressure response compared to the predicate, supporting the conclusion that differences in mode selection, tubing packaging, and device size do not raise different safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →